Ad Watchdog TINA.org Petitions FTC for Made in USA Rule

MADISON, CONN., Aug. 22, 2019 (GLOBE NEWSWIRE) — Consumer advocacy organization, truthinadvertising.org (TINA.org), filed a formal petition today requesting that the Federal Trade Commission (FTC) use its rulemaking authority to expand its enforcement abilities and better defend the Made in… Read moreAd Watchdog TINA.org Petitions FTC for Made in USA Rule

Fast Radius and Curtiss Motorcycles Partner to Create Premium Electric Motorcycles

–Curtiss Presents the Zeus 8 Motorcycle at the Quail Motorsports Gathering in Carmel, California–CHICAGO, Aug. 16, 2019 (GLOBE NEWSWIRE) — Fast Radius and Curtiss Motorcycles today announced a partnership to utilize hybrid manufacturing processes to create the highly-acclaimed Zeus 8… Read moreFast Radius and Curtiss Motorcycles Partner to Create Premium Electric Motorcycles

Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection

DUBLIN, Ireland, Aug. 16, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, announced today that following its receipt of final Type A Meeting… Read moreNabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection

Worldwide Medical Tubing Markets, 2019 to 2025 – Silicone Market Poised to Reach Over $5.2 Billion by 2025

Dublin, Aug. 08, 2019 (GLOBE NEWSWIRE) — The “Medical Tubing – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Medical Tubing market worldwide is projected to grow by US$5.5 Billion, guided by a compounded growth of… Read moreWorldwide Medical Tubing Markets, 2019 to 2025 – Silicone Market Poised to Reach Over $5.2 Billion by 2025

Nabriva Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights

DUBLIN, Ireland, Aug. 08, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today announced its financial results for the three and six months ended… Read moreNabriva Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights

Nabriva Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, today announced that Chief Commercial Officer Francesco… Read moreNabriva Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference

FDA clears new indications for existing Lyme disease tests that may help streamline diagnoses

SILVER SPRING, Md., July 29, 2019 /PRNewswire/ — Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease. The tests cleared today are the first… Read moreFDA clears new indications for existing Lyme disease tests that may help streamline diagnoses